The Biomedical Nanotechnology and Molecular Imaging Laboratory is interested in developing new strategies and technologies for the early detection and treatment of disease. Our current projects focus on creating nanoparticles for drug delivery and molecular imaging with a focus on detection and treatment of atherosclerosis (heart disease) and other inflammatory diseases. The design of nanoparticles at a molecular level can have a large influence on particle function, targetability, and toxicity. By understanding the impact of the chemical building blocks, we aim to create nanoparticles that better detect or treat disease with fewer side effects than conventional agents. The overall motivation of our lab is to better human health through earlier disease detection, more specific detection of disease severity, and improved understanding of the impact of nanoparticles on living systems.
Last Updated: 6/22/15